Björn Dahlbäck
1 – 250 of 274
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Natural anticoagulant discovery, the gift that keeps on giving : finding FV-Short
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Diagnosis and management of severe congenital protein C deficiency (SCPCD) : Communication from the SSC of the ISTH
(
- Contribution to journal › Article
-
Mark
A hydrophobic patch (PLVIVG; 1481–1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S
(
- Contribution to journal › Article
-
Mark
Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
The preAR2 region (1458–1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα
(
- Contribution to journal › Article
- 2021
-
Mark
Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH
(
- Contribution to journal › Article
- 2020
-
Mark
Reduced Apolipoprotein M and Adverse Outcomes across the Spectrum of Human Heart Failure
(
- Contribution to journal › Article
-
Mark
Genetic risk factors for venous thromboembolism
(
- Contribution to journal › Scientific review
-
Mark
Advances in understanding mechanisms of thrombophilic disorders
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Plasma Apolipoprotein M and Sphingosine-1-Phosphate Levels are Inversely Associated with Mortality in African Americans with Type 2 Diabetes Mellitus
(
- Contribution to journal › Article
-
Mark
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short
(
- Contribution to journal › Article
-
Mark
Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2018
-
Mark
Vitamin K–Dependent Protein S : Beyond the Protein C Pathway
(
- Contribution to journal › Article
-
Mark
Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism
(
- Contribution to journal › Article
-
Mark
Treating hemophilia by targeting protein S?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
(
- Contribution to journal › Article
-
Mark
Lean ApoM−/− Mice with Hyperactive Brown Adipose Tissue
(
- Contribution to journal › Article
- 2017
-
Mark
High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1
(
- Contribution to journal › Article
-
Mark
Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier
(
- Contribution to journal › Article
-
Mark
The nanoparticle protein corona formed in human blood or human blood fractions
(
- Contribution to journal › Article
-
Mark
A Shift in ApoM/S1P between HDL-Particles in Women with Type 1 Diabetes Mellitus Is Associated with Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex
(
- Contribution to journal › Article
-
Mark
Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma
(
- Contribution to journal › Letter
-
Mark
Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages
(
- Contribution to journal › Article
-
Mark
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S
(
- Contribution to journal › Article
-
Mark
HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium
(
- Contribution to journal › Article
-
Mark
Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors
(
- Contribution to journal › Article
- 2016
-
Mark
Gas6 fueling tumor-mediated thrombosis.
(
- Contribution to journal › Article
-
Mark
Urinary apolipoprotein M as a biomarker of acute kidney injury in children undergoing heart surgery.
(
- Contribution to journal › Article
-
Mark
Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons
(
- Contribution to journal › Article
-
Mark
Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Epidemiology of Familial Aggregation of Venous Thromboembolism
(
- Contribution to journal › Scientific review
-
Mark
The Gas6-Axl Interaction Mediates Endothelial Uptake of Platelet Microparticles
(
- Contribution to journal › Article
-
Mark
Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders
(
- Contribution to journal › Article
-
Mark
Familial hypercholesterolaemia : cholesterol efflux and coronary disease
(
- Contribution to journal › Article
- 2015
-
Mark
The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
(
- Contribution to journal › Article
-
Mark
Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.
(
- Contribution to journal › Article
-
Mark
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.
(
- Contribution to journal › Article
-
Mark
Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation.
(
- Contribution to journal › Article
-
Mark
Protein Unfolding allow use of Commercial Antibodies in an Apolipoprotein M sandwich ELISA.
(
- Contribution to journal › Article
- 2014
-
Mark
Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
(
- Contribution to journal › Article
-
Mark
The association between apolipoprotein M and insulin resistance varies with country of birth.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Size-Dependent Effects of Nanoparticles on Enzymes in the Blood Coagulation Cascade.
(
- Contribution to journal › Article
-
Mark
TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain
(
- Contribution to journal › Article
-
Mark
Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
(
- Contribution to journal › Article
-
Mark
Targeting exosites of activated protein C as therapeutic possibility?
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Coagulation factor V-A2440G causes east Texas bleeding disorder via TFPI alpha
(
- Contribution to journal › Article
-
Mark
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation
(
- Contribution to journal › Article
- 2012
-
Mark
Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency
(
- Contribution to journal › Article
-
Mark
Biocompatibility of mannan nanogel-safe interaction with plasma proteins
(
- Contribution to journal › Article
-
Mark
The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL
(
- Contribution to journal › Article
-
Mark
Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes
(
- Contribution to journal › Article
-
Mark
Coagulation and inflammation-close allies in health and disease.
(
- Contribution to journal › Article
-
Mark
Polystyrene nanoparticles affecting blood coagulation.
(
- Contribution to journal › Article
- 2011
-
Mark
C4b-Binding Protein: A Forgotten Factor in Thrombosis and Hemostasis
(
- Contribution to journal › Article
-
Mark
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
(
- Contribution to journal › Article
-
Mark
Structural Changes in Apolipoproteins Bound to Nanoparticles
(
- Contribution to journal › Article
-
Mark
Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels: modification by adiposity in nondiabetic subjects
(
- Contribution to journal › Published meeting abstract
-
Mark
Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
(
- Contribution to journal › Article
-
Mark
Activated protein C cofactor function of protein S: a novel role for a gamma-carboxyglutamic acid residue
(
- Contribution to journal › Article
-
Mark
Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects
(
- Contribution to journal › Letter
-
Mark
Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.
(
- Contribution to journal › Article
- 2010
-
Mark
ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATION
2010) 78th Congress of the European-Atherosclerosis-Society In Atherosclerosis Supplements 11(2). p.233-233(
- Contribution to journal › Published meeting abstract
-
Mark
Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain
(
- Contribution to journal › Article
-
Mark
Novel APC-cleavage sites in FVa providing insights into mechanisms of action of APC and its cofactor protein S.
(
- Contribution to journal › Article
-
Mark
Dependence on Vitamin K-dependent Protein S for Eukaryotic Cell Secretion of the beta-Chain of C4b-binding Protein
(
- Contribution to journal › Article
-
Mark
Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.
(
- Contribution to journal › Article
-
Mark
Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men
(
- Contribution to journal › Article
-
Mark
Inhibition of Thrombin Formation by Active Site Mutated (S360A) Activated Protein C
(
- Contribution to journal › Article
-
Mark
Growth arrest specific protein 6 (gas6) and its receptors expression and signalling in beta cells
2010) 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) In Diabetologia 53(Suppl. 1). p.530-530(
- Contribution to journal › Published meeting abstract
-
Mark
Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of apolipoproteins A-I, B, and M in patients with abdominal aortic aneurysms.
(
- Contribution to journal › Article
-
Mark
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms.
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia.
(
- Contribution to journal › Article
-
Mark
The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.
(
- Contribution to journal › Article
-
Mark
Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans.
(
- Contribution to journal › Article
-
Mark
An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA.
(
- Contribution to journal › Article
-
Mark
Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.
(
- Contribution to journal › Article
-
Mark
Plasma levels of apolipoprotein M in normal and complicated pregnancy.
(
- Contribution to journal › Article
-
Mark
Opposing Effects of Apolipoprotein M on Catabolism of Apolipoprotein B-Containing Lipoproteins and Atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of apolipoproteins A-I, B, and M in patients with critical limb ischemia.
(
- Contribution to journal › Article
-
Mark
HDL Stimulates apoM Secretion.
(
- Contribution to journal › Article
-
Mark
Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane.
(
- Contribution to journal › Article
-
Mark
Mouse ApoM Displays an Unprecedented Seven-Stranded Lipocalin Fold: Folding Decoy or Alternative Native Fold?
(
- Contribution to journal › Article
-
Mark
Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction
(
- Contribution to journal › Article
-
Mark
The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype
(
- Contribution to journal › Letter
- 2009
-
Mark
Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness
(
- Contribution to journal › Article
-
Mark
Protein GAS6 and its receptor Axl are expressed and operate in pancreatic beta cells
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.448-448(
- Contribution to journal › Published meeting abstract
-
Mark
ApoM: gene regulation and effects on HDL metabolism
(
- Contribution to journal › Scientific review
-
Mark
Serendipitous Fatty Acid Binding Reveals the Structural Determinants for Ligand Recognition in Apolipoprotein M
(
- Contribution to journal › Article
-
Mark
Expression Of Apolipoprotein M In Fetal Liver: Impact Of Maternal Diabetes
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.714-714(
- Contribution to journal › Published meeting abstract
-
Mark
Anticoagulant Properties Of Apolipoprotein A-I And Phospholipid Transfer Protein
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.138-138(
- Contribution to journal › Published meeting abstract
-
Mark
Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects
(
- Contribution to journal › Article
-
Mark
Recombinant Apolipoprotein M Secretion Stimulated By HDL
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.1175-1175(
- Contribution to journal › Published meeting abstract
-
Mark
Anionic Phospholipids Lose their Procoagulant Properties when Incorporated into High-Density Lipoproteins.
(
- Contribution to journal › Article
-
Mark
Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
(
- Contribution to journal › Article
-
Mark
Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?
(
- Contribution to journal › Article
-
Mark
Mouse recombinant protein C variants with enhanced membrane affinity and hyper-anticoagulant activity in mouse plasma.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M is decreased in type 2 diabetes and affects pre beta high density lipoprotein formation and cellular cholesterol efflux
(
- Contribution to journal › Published meeting abstract
-
Mark
Complete high-density lipoproteins in nanoparticle corona.
(
- Contribution to journal › Article
-
Mark
Relationship Between Plasma Apolipoprotein-M And High Density Lipoprotein Apoa Kinetics In Men
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.729-729(
- Contribution to journal › Published meeting abstract
-
Mark
Platelet Factor 4 Impairs the Anticoagulant Activity of Activated Protein C
(
- Contribution to journal › Article
- 2008
-
Mark
Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin
(
- Contribution to journal › Article
-
Mark
The signal peptide anchors apolipoprotein m in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma
(
- Contribution to journal › Article
-
Mark
Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies
(
- Contribution to journal › Article
-
Mark
Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice
(
- Contribution to journal › Article
-
Mark
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
(
- Contribution to journal › Article
-
Mark
The Tensin Family Of Putative Metastasis Suppressor Proteins Are Down-Regulated In Human Kidney Cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
The signal peptide anchors apolipoprotein m in plasma lipoproteins and prevents rapid clearance of apolipoprotein m from plasma
2008) Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2008 In Arteriosclerosis, Thrombosis, and Vascular Biology 28(6). p.62-63(
- Contribution to journal › Published meeting abstract
-
Mark
Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M: structure and function
(
- Contribution to journal › Scientific review
-
Mark
Lipid metabolism: why is apoM an apolipoprotein?
(
- Contribution to journal › Article
-
Mark
Early days of APC resistance and FV Leiden.
(
- Contribution to journal › Article
-
Mark
Carriership of factor v leiden and evolutionary selection advantage.
(
- Contribution to journal › Article
-
Mark
Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va.
(
- Contribution to journal › Article
-
Mark
Advances in understanding pathogenic mechanisms of thrombophilic disorders.
(
- Contribution to journal › Article
-
Mark
Mapping of the factor Xa-binding site on factor Va by site-directed mutagenesis.
(
- Contribution to journal › Article
-
Mark
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M associates to lipoproteins through its retained signal peptide.
(
- Contribution to journal › Article
-
Mark
Human activated protein C variants in a rat model of arterial thrombosis
(
- Contribution to journal › Article
- 2007
-
Mark
C4b-binding protein and factor h compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack
(
- Contribution to journal › Article
-
Mark
An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma
(
- Contribution to journal › Article
-
Mark
Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M
(
- Contribution to journal › Article
-
Mark
The tale of protein S and C4b-binding protein, a story of affection
(
- Contribution to journal › Article
-
Mark
Coagulation factorV and thrombophilia: Background and mechanisms
(
- Contribution to journal › Article
-
Mark
Downregulation of C1-TEN expression in human cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
The role of thrombin exosites I and II in the activation of human coagulation factor V
(
- Contribution to journal › Article
-
Mark
Antithrombotic and anticoagulant effects of wild type and Gla-domain mutated human activated protein C in rats.
(
- Contribution to journal › Article
- 2006
-
Mark
Apolipoprotein M - a novel player in high-density lipoprotein metabolism and atherosclerosis.
(
- Contribution to journal › Scientific review
-
Mark
Isolation and characterization of human apolipoprotein M-containing lipoproteins
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance - in the absence of factor V Leiden - and pregnancy.
(
- Contribution to journal › Article
-
Mark
Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.
(
- Contribution to journal › Scientific review
-
Mark
Multifunctional specificity of the protein C/activated protein C Gla domain
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M: Progress in understanding its regulation and metabolic functions
(
- Contribution to journal › Scientific review
-
Mark
Proposed structural models of the prothrombinase (FXa-FVa) complex
(
- Contribution to journal › Article
-
Mark
Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.
(
- Contribution to journal › Scientific review
-
Mark
Megalin is a receptor for apolipoprotein M and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M.
(
- Contribution to journal › Article
-
Mark
Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va.
(
- Contribution to journal › Article
- 2005
-
Mark
Analysis of Gas6 in Human Platelets and Plasma.
(
- Contribution to journal › Article
-
Mark
The importance of the protein C system in the pathogenesis of venous thrombosis.
(
- Contribution to journal › Article
-
Mark
Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway. Novel Insights Into Structure-Function Relationships and Molecular Recognition.
(
- Contribution to journal › Scientific review
-
Mark
The anticoagulant protein C pathway.
(
- Contribution to journal › Scientific review
-
Mark
C1-TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration
(
- Contribution to journal › Article
-
Mark
Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation
(
- Contribution to journal › Article
-
Mark
Large deletions of the PROS1 gene in a large fraction of mutationnegative patients with protein S deficiency
(
- Contribution to journal › Article
-
Mark
The Ran binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases.
(
- Contribution to journal › Article
-
Mark
Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.
(
- Contribution to journal › Scientific review
-
Mark
Molecular coagulation and thrombophilia.
2005) p.158-158(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2004
-
Mark
Progress in the understanding of the protein C anticoagulant pathway.
(
- Contribution to journal › Article
-
Mark
Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H.
(
- Contribution to journal › Article
-
Mark
Identification of the MMRN1 binding region within the C2 domain of human factor V
(
- Contribution to journal › Article
-
Mark
The multiple faces of the partial thromboplastin time APTT.
(
- Contribution to journal › Letter
-
Mark
Functional characterization of Factor V-Ile359Thr, a novel mutation associated with thrombosis.
(
- Contribution to journal › Article
-
Mark
Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1.
(
- Contribution to journal › Article
-
Mark
The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells.
(
- Contribution to journal › Article
-
Mark
Ligand recognition and homophilic interactions in Tyro3 - Structural insights into the Axl/Tyro3 receptor tyrosine kinase family
(
- Contribution to journal › Article
-
Mark
Enhanced rate of cleavage at Arg306 and Arg506 in coagulation factor Va by Gla domain-mutated human activated protein C.
(
- Contribution to journal › Article
-
Mark
Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts.
(
- Contribution to journal › Article
-
Mark
Altered inactivation pathway of factor Va by activated protein C in the presence of heparin
(
- Contribution to journal › Article
-
Mark
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?
(
- Contribution to journal › Scientific review
-
Mark
Functions of human complement inhibitor C4b-binding protein in relation to its structure.
(
- Contribution to journal › Scientific review
-
Mark
Anticoagulant factor V and thrombosis risk
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Functional properties of recombinant factor V mutated in a potential calcium-binding site.
(
- Contribution to journal › Article
-
Mark
Characterization of apoM in normal and genetically modified mice
(
- Contribution to journal › Article
- 2003
-
Mark
Factor VI359T: a novel mutation associated with thrombosis and resistance to activated protein C
(
- Contribution to journal › Article
-
Mark
Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding
(
- Contribution to journal › Article
-
Mark
Molecular recognition in the protein C anticoagulant pathway.
(
- Contribution to journal › Article
-
Mark
Successful hunt for quantitative trait locus in thrombophilia
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The binding of protein S and the protein S-C4BP complex to neutrophils is apoptosis dependent.
(
- Contribution to journal › Article
-
Mark
The discovery of activated protein C resistance.
(
- Contribution to journal › Article
-
Mark
Gla-domain mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding.
(
- Contribution to journal › Article
-
Mark
Congenital and acquired activated protein C resistance.
(
- Contribution to journal › Article
-
Mark
Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein (C4BP) activates B cells through the CD40 receptor
(
- Contribution to journal › Article
-
Mark
Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury.
(
- Contribution to journal › Article
-
Mark
CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
(
- Contribution to journal › Article
-
Mark
Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women.
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance (FVLeiden) and thrombosis: factor V mutations causing hypercoagulable states
(
- Contribution to journal › Scientific review
-
Mark
Diagnosing protein S deficiency: analytical considerations.
(
- Contribution to journal › Article
-
Mark
Factor V Leiden in pregnancies complicated by placental abruption
(
- Contribution to journal › Article
-
Mark
Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein S.
(
- Contribution to journal › Article
-
Mark
Role of CCP2 of the C4b-binding protein beta-chain in protein S binding evaluated by mutagenesis and monoclonal antibodies.
(
- Contribution to journal › Article
-
Mark
Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
(
- Contribution to journal › Article
-
Mark
Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.
(
- Contribution to journal › Article
- 2002
-
Mark
Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site.
(
- Contribution to journal › Article
-
Mark
Functional characterization of recombinant FV Hong Kong and FV Cambridge.
(
- Contribution to journal › Article
-
Mark
Factor V Leiden and the genetics of myocardial infarction: we need to look elsewhere.
(
- Contribution to journal › Article
-
Mark
Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype.
(
- Contribution to journal › Article
-
Mark
Rapid intracellular degradation of a truncated mutant protein S (Q522X)
(
- Contribution to journal › Letter
-
Mark
Individual risk assessment of thrombosis in pregnancy.
(
- Contribution to journal › Article
-
Mark
Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S
(
- Contribution to journal › Article
-
Mark
Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin.
(
- Contribution to journal › Article
-
Mark
Vitamin k-dependent protein s localizing complement regulator c4b-binding protein to the surface of apoptotic cells.
(
- Contribution to journal › Article
-
Mark
Structural requirements of anticoagulant protein S for its binding to the complement regulator c4b-binding protein
(
- Contribution to journal › Article
-
Mark
Genetic and phenotypic variability between families with hereditary protein S deficiency
(
- Contribution to journal › Article
-
Mark
Factor V and thrombotic disease: description of a janus-faced protein.
(
- Contribution to journal › Scientific review
-
Mark
Defining the factor Xa-binding site on factor Va by site-directed glycosylation.
(
- Contribution to journal › Article
-
Mark
Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein.
(
- Contribution to journal › Article
- 2001
-
Mark
C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae
(
- Contribution to journal › Scientific review
-
Mark
Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C
(
- Contribution to journal › Article
-
Mark
Localization of a hydrophobic binding site for anticoagulant protein S on the beta -chain of complement regulator C4b-binding protein
(
- Contribution to journal › Article
-
Mark
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
(
- Contribution to journal › Article
-
Mark
Analytical considerations for free protein S assays in protein S deficiency
(
- Contribution to journal › Article
-
Mark
A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4B-binding protein
(
- Contribution to journal › Article
-
Mark
Binding of C4b-binding protein: A molecular mechanism of serum resistance of Neisseria gonorrhoeae
(
- Contribution to journal › Article
-
Mark
Screening the molecular surface of human anticoagulant protein C: a search for interaction sites
(
- Contribution to journal › Article
-
Mark
Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis
(
- Contribution to journal › Article
-
Mark
Three-dimensional model of the SHBG-like region of anticoagulant protein S: New structure-function insights
(
- Contribution to journal › Article
-
Mark
Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden--an evolutionary advantage?
(
- Contribution to journal › Letter
-
Mark
Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b
(
- Contribution to journal › Article
-
Mark
Structural requirements for the complement regulatory activities of C4BP
(
- Contribution to journal › Article
- 2000
-
Mark
Använd hela "analyspaketet" vid utredning av trombospatienten! Och glöm inte släktingarna ...
(
- Contribution to journal › Article
- 1999
-
Mark
Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling
(
- Contribution to journal › Article
-
Mark
Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
Thrombophilia as a multigenic disease
(
- Contribution to journal › Article
- 1998
-
Mark
Activated protein C resistance in patients with peripheral vascular disease
(
- Contribution to journal › Article
-
Mark
A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency
(
- Contribution to journal › Article
-
Mark
A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen
(
- Contribution to journal › Article
-
Mark
Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect
(
- Contribution to journal › Article
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
(
- Contribution to journal › Letter
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [3]
(
- Contribution to journal › Letter
-
Mark
Association of vitamin K dependent coagulation proteins and C4b binding proteins with triglyceride rich proteins of human plasma
(
- Contribution to journal › Article
-
Mark
Activation of the contact-phase system on bacterial surfaces - A clue to serious comlications in infections deseases
(
- Contribution to journal › Article
- 1997
-
Mark
The factor VR5O6Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
(
- Contribution to journal › Article
-
Mark
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance caused by a common factor V mutation has a single origin
(
- Contribution to journal › Article
-
Mark
The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
(
- Contribution to journal › Article
-
Mark
Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance : Clinical implications
(
- Contribution to journal › Scientific review
-
Mark
Presence of vitamin K dependent coagulation proteins in isolated lipoproteins from human plasma.
(
- Contribution to journal › Article
-
Mark
The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function
(
- Contribution to journal › Article
-
Mark
Molecular cloning of rat C4b binding protein alpha- and beta-chains : structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins
(
- Contribution to journal › Article
- 1996
-
Mark
Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
(
- Contribution to journal › Article
-
Mark
Resistance to activated protein C due to a factor V gene mutation : The most common inherited risk factor of thrombosis
(
- Contribution to journal › Article
-
Mark
Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries
(
- Contribution to journal › Article
-
Mark
Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis
(
- Contribution to journal › Scientific review
-
Mark
High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
(
- Contribution to journal › Letter
-
Mark
Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis
(
- Contribution to journal › Article
-
Mark
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance as a basis for venous thrombosis.
(
- Contribution to journal › Article
- 1995
-
Mark
Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance : from phenotype to genotype and clinical practice
(
- Contribution to journal › Article
-
Mark
Resistens mot aktiverat protein C. Vanlig genetisk riskfaktor för venös trombos
(
- Contribution to journal › Article